Skip to content
(614)355-5560
West Region
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids

Since the discontinuation of brand name Flovent®, there have been many challenges with patient access to spacer-compatible inhaled steroids that are appropriate for children with asthma. Even though fluticasone propionate HFA (authorized generic of Flovent®), is a covered option for Ohio Medicaid patients, there still may be shortages at the pharmacy to overcome. In response, Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children.  Included in this resource is standard language that will assist with proper communication to insurance companies if a prior authorization is requested. 

If you have questions, please reach out to the Partners For Kids pharmacy team at PFKPharmacy@ChildrensDayton.org

Related Articles
Pharmacy Updates
January 16, 2025
Quarterly Update for Partners For Kids’ Pediatric Unified Preferred Drug List (UPDL) – 1/2025
Partners For Kids’ UPDL for Ohio Medicaid Plans is now available.
Read More
Pharmacy Updates
January 16, 2025
Constipation Over-The-Counter Medication Guide
Read More
Pharmacy Updates
January 16, 2025
Constipation Over-The-Counter Medication Guide
Read More
Pharmacy Updates
January 16, 2025
Access to Spacers Improved for Patients with Asthma
Read More
Pharmacy Updates
January 16, 2025
Access to Spacers Improved for Patients with Asthma
Read More
Pharmacy Updates
January 16, 2025
Quarterly Update for Partners For Kids’ Pediatric Unified Preferred Drug List (UPDL) – 1/2025
Partners For Kids’ UPDL for Ohio Medicaid Plans is now available.
Read More